These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2654132)

  • 21. Re: urokinase and urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
    Hasui Y; Osada Y
    J Natl Cancer Inst; 1997 Nov; 89(21):1630-1. PubMed ID: 9362166
    [No Abstract]   [Full Text] [Related]  

  • 22. Re: urokinase and urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
    Duffy MJ; Duggan C
    J Natl Cancer Inst; 1997 Nov; 89(21):1628-30. PubMed ID: 9362165
    [No Abstract]   [Full Text] [Related]  

  • 23. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
    Mohanam S; Chandrasekar N; Yanamandra N; Khawar S; Mirza F; Dinh DH; Olivero WC; Rao JS
    Oncogene; 2002 Nov; 21(51):7824-30. PubMed ID: 12420219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive and metastatic potential induced by ras-transfection into mouse BW5147 T-lymphoma cells.
    Collard JG; Schijven JF; Roos E
    Cancer Res; 1987 Feb; 47(3):754-9. PubMed ID: 3802080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
    J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines.
    Hudson MA; McReynold LM
    Adv Exp Med Biol; 1999; 462():399-412. PubMed ID: 10599442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antisense inhibition of urokinase in a human osteosarcoma cell line].
    Haeckel C; Krueger S; Roessner A
    Verh Dtsch Ges Pathol; 1998; 82():170-7. PubMed ID: 10095429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P53-mediated radioresistance does not correlate with metastatic potential in tumorigenic rat embryo cell lines following oncogene transfection.
    Bristow RG; Brail L; Jang A; Peacock J; Chung S; Benchimol S; Hill RP
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):341-55. PubMed ID: 8567335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of E1AF/PEA3, an Ets-related transcription factor in human non-small-cell lung cancers: its relevance in cell motility and invasion.
    Hiroumi H; Dosaka-Akita H; Yoshida K; Shindoh M; Ohbuchi T; Fujinaga K; Nishimura M
    Int J Cancer; 2001 Sep; 93(6):786-91. PubMed ID: 11519038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
    Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
    Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.
    Tuck AB; Arsenault DM; O'Malley FP; Hota C; Ling MC; Wilson SM; Chambers AF
    Oncogene; 1999 Jul; 18(29):4237-46. PubMed ID: 10435636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells.
    Liu G; Shuman MA; Cohen RL
    Int J Cancer; 1995 Feb; 60(4):501-6. PubMed ID: 7829264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a.
    Garbisa S; Pozzatti R; Muschel RJ; Saffiotti U; Ballin M; Goldfarb RH; Khoury G; Liotta LA
    Cancer Res; 1987 Mar; 47(6):1523-8. PubMed ID: 3028610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/scid mice.
    Mueller BM; Yu YB; Laug WE
    Proc Natl Acad Sci U S A; 1995 Jan; 92(1):205-9. PubMed ID: 7816818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2.
    Billottet C; Janji B; Thiery JP; Jouanneau J
    Oncogene; 2002 Nov; 21(53):8128-39. PubMed ID: 12444548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of urokinase-type plasminogen activator expression in squamous-cell carcinoma of the oral cavity.
    Clayman G; Wang SW; Nicolson GL; el-Naggar A; Mazar A; Henkin J; Blasi F; Goepfert H; Boyd DD
    Int J Cancer; 1993 Apr; 54(1):73-80. PubMed ID: 8386710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marked acceleration of the metastatic phenotype of a rat bladder carcinoma cell line by the expression of human gelatinase A.
    Kawamata H; Kameyama S; Kawai K; Tanaka Y; Nan L; Barch DH; Stetler-Stevenson WG; Oyasu R
    Int J Cancer; 1995 Nov; 63(4):568-75. PubMed ID: 7591268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene.
    Kyprianou N; Isaacs JT
    Cancer Res; 1990 Mar; 50(5):1449-54. PubMed ID: 2105838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation.
    Quax PH; van Muijen GN; Weening-Verhoeff EJ; Lund LR; Danø K; Ruiter DJ; Verheijen JH
    J Cell Biol; 1991 Oct; 115(1):191-9. PubMed ID: 1918136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells.
    Wilhelm O; Weidle U; Höhl S; Rettenberger P; Schmitt M; Graeff H
    FEBS Lett; 1994 Jan; 337(2):131-4. PubMed ID: 8287966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.